XBiotech Inc. — Investor Relations & Filings
XBiotech Inc. is a fully integrated biosciences company focused on the discovery and development of therapeutic antibodies. The company's proprietary True Human™ antibody platform identifies and clones antibodies directly from individuals who possess natural immunity to specific diseases. This approach is distinct from 'humanized' or other 'fully human' antibody technologies. XBiotech's clinical research and development pipeline addresses a range of unmet medical needs, with programs in therapeutic areas such as oncology, neurology, rheumatology, and anti-infectives. A key focus of its development is on therapies that target interleukin-1α (IL-1α), a substance that can cause harmful inflammation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q | 2026-05-14 | English | |
| 10-K/A - XBiotech Inc. (0001626878) (Filer) | 2026-04-29 | English | |
| SCHEDULE 13G/A Filing | 2026-01-23 | English | |
| SCHEDULE 13G/A Filing | 2026-01-23 | English | |
| FORM 8-K | 2025-12-09 | English | |
| FORM 10-Q | 2025-11-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 46198938 | FORM 10-Q | 2026-05-14 | English | ||
| 38702866 | 10-K/A - XBiotech Inc. (0001626878) (Filer) | 2026-04-29 | English | ||
| 30996341 | SCHEDULE 13G/A Filing | 2026-01-23 | English | ||
| 30996326 | SCHEDULE 13G/A Filing | 2026-01-23 | English | ||
|
2025
11 filings
| |||||
| 12834411 | FORM 8-K | 2025-12-09 | English | ||
| 12834412 | FORM 10-Q | 2025-11-12 | English | ||
| 12834413 | 4 | 2025-11-12 | English | ||
| 12834414 | 4 | 2025-11-12 | English | ||
| 12834415 | 4 | 2025-11-12 | English | ||
| 12834416 | 4 | 2025-11-12 | English | ||
| 12834417 | FORM 8-K/A | 2025-10-15 | English | ||
| 12834421 | FORM 8-K | 2025-10-03 | English | ||
| 12834422 | 3 | 2025-09-30 | English | ||
| 12834423 | 3 | 2025-09-30 | English | ||
| 12834424 | 3 | 2025-09-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
XBiotech Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34229/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34229 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34229 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34229 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34229}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for XBiotech Inc. (id: 34229)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.